Beyond the Elevator Pitch | Inside Start-up Stories | Part 6

What if we could make cutting-edge cell therapies accessible to all, regardless of financial status? 🌍

CYTEA BIO is turning this vision into reality.

As HeadhunterAngels, we celebrate innovative biotech startups that are making a difference. Today, we’re excited to introduce CYTEA BIO, a Swiss-French biotech company based in Montpellier:

CYTEA BIO is addressing the urgent need for affordable and scalable cell therapies. Their groundbreaking 𝐏𝐒𝐧ℒ 𝐏π₯𝐚𝐭𝐟𝐨𝐫𝐦 enables the production of powerful antibody-cell conjugates, revolutionizing treatments for cancers and immune diseases.

Key innovations include:

🧬 Modular 𝐏𝐒𝐧ℒ 𝐏π₯𝐚𝐭𝐟𝐨𝐫𝐦: creating flexible, powerful treatments for oncology and immunology.

πŸ§ͺ Affordable solutions: reducing the costs of cell therapies, making them more accessible.

πŸ’‰ High-efficacy treatments: enhancing patient outcomes with minimal side effects.

🌍 Global impact: offering hope to patients worldwide, irrespective of wealth.

πŸ“– Read the full interview with COO Marc CRITON and learn more about how CYTEA BIO is transforming the future of cell therapy!

 

Startup_presentation_CYTEA